Potassium%252525252520chloride

## Potassium Chloride ### Overview Potassium chloride (KCl) is an electrolyte replacement. It is crucial for nerve conduction, muscle contraction, and maintaining acid-base balance. ### Primary Indications * Treatment and prevention of hypokalemia. ### Adult Dosing * **Prevention of Hypokalemia:** Typically 20-40 mEq daily, administered orally in 1-2 divided doses. * **Treatment of Hypokalemia:** * **Oral:** 40-100 mEq daily, administered in 2-4 divided doses. Maximum oral dose usually 100 mEq daily. * **Intravenous (IV):** Dosing is highly individualized based on serum potassium levels and clinical status. **IV potassium must be administered via infusion pump and never given IV push.** * Mild hypokalemia (3.0-3.5 mEq/L): Typically 20-40 mEq in 1 L of IV fluid over 2-6 hours. * Moderate hypokalemia (2.5-3.0 mEq/L): Typically 40-60 mEq in 1 L of IV fluid over 4-8 hours. * Severe hypokalemia (<2.5 mEq/L) or ECG changes: May require higher doses and more rapid infusion, **often dictated by local hospital protocol or critical care guidelines.** Maximum infusion rate is typically 20 mEq/hour, but can be increased to 40 mEq/hour in life-threatening situations with continuous cardiac monitoring. Maximum concentration for peripheral IV administration is usually 40 mEq/L; higher concentrations may be given centrally. ### Pediatric Dosing * Dosing is based on body weight and serum potassium levels. **Specific dosing should be guided by institutional protocols or expert consultation.** * **Oral:** 2-5 mEq/kg/day in divided doses. Maximum daily dose usually 100 mEq. * **Intravenous (IV):** Dosing is highly individualized. Commonly initiated at 0.5-1 mEq/kg/dose administered over 1-3 hours, adjusted based on response. Maximum infusion rates and concentrations are similar to adults but should be strictly adhered to due to increased pediatric risk. ### Dose Adjustments * **Renal Impairment:** Use with extreme caution and often requires significant dose reduction or avoidance. Monitor potassium levels closely. * **Adrenal Insufficiency:** May require lower doses. ### Contraindications * Hyperkalemia. * Conditions causing increased potassium levels (e.g., renal failure, untreated Addison's disease, severe tissue trauma). * Known hypersensitivity to potassium chloride. ### Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal discomfort (oral). * **Serious:** Hyperkalemia (manifested by muscle weakness, paralysis, cardiac arrhythmias, cardiac arrest), phlebitis or tissue necrosis at IV site if extravasation occurs. ### Key Drug Interactions * **ACE Inhibitors, ARBs, Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene), NSAIDs, Heparin:** Increase the risk of hyperkalemia. * **Loop and Thiazide Diuretics:** Can increase potassium loss, potentially necessitating higher KCl doses. ### Monitoring * **Serum potassium levels:** Frequency depends on route of administration, dose, renal function, and clinical status. Initially, monitor frequently (e.g., every 4-6 hours after IV initiation), then less frequently as stable. * **Renal function (BUN, creatinine):** Crucial, especially in patients with impaired renal function. * **ECG:** Particularly important for IV potassium administration and in patients with severe hypokalemia or risk factors for hyperkalemia. * **Signs and symptoms of hypokalemia and hyperkalemia.** ### Clinical Pearls * Oral liquid formulations can be very unpalatable; consider solid dosage forms or dilution. * Always dilute IV potassium before administration; never give as an undiluted bolus. * Use an infusion pump for all IV potassium administration. * Monitor urine output to ensure adequate renal function before and during therapy. * Be aware of other medications that can affect potassium levels. *** **Disclaimer:** This information is intended for clinical decision support and does not replace comprehensive drug information resources. Always consult the most current prescribing information and institutional protocols before making any treatment decisions.